NORDOVO BIOSCIENCES AS

Keywords

laboratory equipmentlaboratory furnituresurgicalmedicalinstrumentssurgical equipmentdental technologyequipmentorthodonticgoodsdental prosthesesorthodontic appliancestooth fillingsdental cementsadhesivesdental waxplaster preparationslaboratory ovensultrasonic cleaning machineslaboratory sterilization equipmentsyringesneedlescathetersdental chairsartificial teethbridgeshearing aidsglass eyesthermometersvision aidsglasseslensescontact lenses and gogglescardiac pacemakerslaboratory distillation apparatuslaboratory centrifuges

Organization

CEO: AH
Armend Gazmeno Håti1988
Chairman of the board: AA
Andreas Alfred Lehmann1984
Years since formation: 6 years; since Sep 3, 2018
Type: Limited company
VAT registered: Yes
Number of employees: 7

Ownership

Number of shares and share classes: 30,000; 1 share class
Total number of shareholders: 4; 2 companies, 2 persons
Belongs to group of

Financials

Total operating income 2023: 1,151,297; NOK
Annual total result 2023: -7,362,140; NOK
Total equity 2023: 16,048,176; NOK

Last update: Oct 14, 2024

Management

Management / administration

Name	Role	Shares
AH Armend Gazmeno Håti 1988	Managing Director/CEO	88 % indirectly

Board

Name	Role	Shares
AH Armend Gazmeno Håti 1988	Board Member	88 % indirectly
AA Andreas Alfred Lehmann 1984	Chairman	-
WQ Wasim Qamar Malik 1978	Board Member	-
AT Anders Tuv 1978	Board Member	-

Others

Name	Role	Shares
C COMPLÉR ACCOUNTING AS	Accountant	-
F FORVIS MAZARS AS	Auditor	-

Top 10 individual shareholders

Name	Role	Shares
AH Armend Gazmeno Håti 1988	Managing Director/CEO, Board Member	88 % indirectly
MB Manuel Boris Schweikle 1987	-	5 % indirectly

Last update: Nov 12, 2024

Ownership

Company shareholders

Name	Share class	Number of shares	Share
H H10 HOLDING AS	Ordinary shares	26,400	88 %
N NEUE HOLDING AS	Ordinary shares	1,500	5 %
LA Lehmann Andreas	Ordinary shares	1,500	5 %
CD C Basset David	Ordinary shares	600	2 %

Last update: May 24, 2024

Group structure

H10 HOLDING AS
Total operating income 2023: NOK 0
Operating profit 2023: NOK -200,006
Employees: 0

Financials

in NOK

Summary

Year	2023	2022	2021
Total operating income	1,151,297	1,477,428	19,846
Annual Total Result	-7,362,140	-4,197,638	-4,094,894
Total assets	19,242,880	15,575,996	7,839,010
Total liabilities	3,194,704	3,708,310	1,546,664
Total equity	16,048,176	11,867,686	6,292,346

P&L

Year	2023	2022	2021
Total operating income	1,151,297	1,477,428	19,846
Total operating costs	8,498,943	5,680,842	4,108,147
Operating result	-7,347,646	-4,203,414	-4,088,301
Financial income/costs	-14,494	5,776	-6,593
Profit before tax	-7,362,140	-4,197,638	-4,094,894
Total tax & extraordinary income/cost	0	0	0
Annual Total Result	-7,362,140	-4,197,638	-4,094,894

Balance overview

Year	2023	2022	2021
Total fixed assets	3,476,145	1,216,358	0
Total current assets	15,766,735	14,359,638	7,839,010
Total assets	19,242,880	15,575,996	7,839,010
Short term debt	3,067,204	3,539,810	1,546,664
Long term debt	127,500	168,500	0
Total liabilities	3,194,704	3,708,310	1,546,664
Contributed capital	31,731,782	20,189,151	10,416,173
Retained earnings	-15,683,606	-8,321,465	-4,123,827
Total equity	16,048,176	11,867,686	6,292,346
Total equity and liabilities	19,242,880	15,575,996	7,839,010

NORDOVO BIOSCIENCES AS921 331 312